Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Jiahong Lyu"'
Autor:
Jiahong Lyu MS, Guohua Yu MD, PhD, Yunyun Zhang MS, Yan Lyu MS, Wenfeng Zhang MS, Jiandi Zhang PhD, Fangrong Tang MS
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Background: Extensive amounts of archived formalin fixed paraffin embedded (FFPE) human tumor tissues are the ultimate resource to investigate signaling network underlying tumorigenesis in human. Yet, their usage is severely limited for lacking of su
Externí odkaz:
https://doaj.org/article/7b1d263800fc4a919ea677afa98fca6a
Autor:
Junmei Hao, Wenfeng Zhang, Yan Lyu, Jiarui Zou, Yunyun Zhang, Jiahong Lyu, Jianbo Zhang, Shuishan Xie, Cuiping Zhang, Jiandi Zhang, Fangrong Tang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundKi67 is a biomarker of proliferation to be used in immunohistochemistry (IHC)-based surrogate assay to determine the necessity of cytotoxic therapy for Luminal-like breast cancer patients. cyclinD1 is another frequently used biomarker of pr
Externí odkaz:
https://doaj.org/article/7d3287aa92df48ea9ea56251068666fa
Autor:
Junmei Hao, Yan Lyu, Jiarui Zou, Yunyun Zhang, Shuishan Xie, Lili Jing, Fangrong Tang, Jiahong Lyu, Wenfeng Zhang, Jianbo Zhang, Xunting Wang, Kuisheng Chen, Jiandi Zhang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundImmunohistochemistry (IHC)-based surrogate assay is the prevailing method in daily clinical practice to determine the necessity of chemotherapy for Luminal-like breast cancer patients worldwide. It relies on Ki67 scores to separate Luminal
Externí odkaz:
https://doaj.org/article/e82aec88a4024376800762dc0f96613e
Autor:
Guohua Yu, Jiahong Lyu, Yalun Li, Yunyun Zhang, Yan Lyu, Wengfeng Zhang, Jianbo Zhang, Bocheng Cai, Jiandi Zhang, Fangrong Tang
Publikováno v:
Journal of Clinical Laboratory Analysis. 36
To translate a clinical research finding into daily clinical practice requires well-controlled clinical trials. We have demonstrated the usage of absolute quantitation of Ki67 and cyclinD1 protein levels to improve prognosis of Luminal-like patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c368abc69905d1931b41b67c6e43c974
https://doi.org/10.1002/jcla.24601
https://doi.org/10.1002/jcla.24601
Autor:
Yan Lyu, Jianbo Zhang, Fangrong Tang, Jiarui Zou, Cuiping Zhang, Jiandi Zhang, Junmei Hao, Yunyun Zhang, Shuishan Xie, Jiahong Lyu, Wenfeng Zhang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundKi67 is a biomarker of proliferation to be used in immunohistochemistry (IHC)-based surrogate assay to determine the necessity of cytotoxic therapy for Luminal-like breast cancer patients. cyclinD1 is another frequently used biomarker of pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f70c951be9805f3986ed1910ef105492
https://www.frontiersin.org/articles/10.3389/fonc.2021.737794/full
https://www.frontiersin.org/articles/10.3389/fonc.2021.737794/full
Autor:
Wenfeng Zhang, Jiandi Zhang, Jianbo Zhang, Jiahong Lyu, Yunyun Zhang, Junmei Hao, Yan Lyu, Jiarui Zou, Kui-Sheng Chen, Fangrong Tang, Shuishan Xie, Xunting Wang, Lili Jing
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundImmunohistochemistry (IHC)-based surrogate assay is the prevailing method in daily clinical practice to determine the necessity of chemotherapy for Luminal-like breast cancer patients worldwide. It relies on Ki67 scores to separate Luminal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::801d36c6eea388f4e6a0eaf7d2fbdadf
https://doi.org/10.21203/rs.3.rs-437768/v1
https://doi.org/10.21203/rs.3.rs-437768/v1
Autor:
Xiaoyu Li, Di Shan, Hu Long, Fan Jian, Jiahong Lyu, H Liang, Wenli Lai, Yan Wang, Xinyu Yan, H Hu
Publikováno v:
Journal of dental research. 100(1)
Calcitonin gene-related peptide (CGRP) plays a crucial role in the modulation of orofacial pain, and we hypothesized that CGRP mediated a neuron-glia crosstalk in orofacial pain. The objective of this study was to elucidate the mechanisms whereby CGR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5b63345ae72a1d3bdf62868fc282e17
https://pubmed.ncbi.nlm.nih.gov/32853530
https://pubmed.ncbi.nlm.nih.gov/32853530
Publikováno v:
Journal of Aligner Orthodontics; 2022, Vol. 6 Issue 1, p17-29, 13p
Autor:
Hang Wang, Hengyan Liang, Rui Guo, Yafen Zhu, Meiya Gao, Wenli Lai, Jing Wen, Jiahong Lyu, Hu Long
Publikováno v:
Archives of Oral Biology. 117:104817
Objectives To investigate the effect and mechanism of botulinum neurotoxin type A (BoNT/A) in the modulation of orofacial nociception induced by orthodontic tooth movement in rats. Methods An orofacial nociception model was established in male Spragu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc107f9ab42cc2b378a4716cffc27818
https://doi.org/10.1016/j.archoralbio.2020.104817
https://doi.org/10.1016/j.archoralbio.2020.104817
Publikováno v:
Journal of Physics D: Applied Physics. 53:245401
A novel magnetic drug-loaded osteoinductive Fe3O4/CaCO3 hybrid microspheres system (MDHMs) with excellent drug delivery property has been fabricated by a modified coprecipitation method. The MDHMs are uniform vaterite microspheres with well-defined m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdfd3623b8248bd2dfdf9eb26dcca72a
https://doi.org/10.1088/1361-6463/ab7bb2
https://doi.org/10.1088/1361-6463/ab7bb2